CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder

Hongsik Kim, Byong Chang Jeong, Joohyun Hong, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Wan Song, Hyun Hwan Sung, Jung Yong Hong, Se Hoon Park

Cancer Research and Treatment. 2023;55(2):636-642. Published online 2022 October 6 DOI: https://doi.org/10.4143/crt.2022.343

Commentary on A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: A retrospective experience

H. Barton Grossman

Urologic Oncology: Seminars and Original Investigations. 2009;27(3):338

Link1 Link2

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder

Hongsik Kim, Byong Chang Jeong, Joohyun Hong, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Wan Song, Hyun Hwan Sung, Jung Yong Hong, Se Hoon Park

Cancer Research and Treatment. 2023;55(2):636-642

Link1

Link2 Link3

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder

Atreya Dash, Joseph A. Pettus, Harry W. Herr, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Paul Russo, Mary G. Boyle, Matthew I. Milowsky, Dean F. Bajorin

Cancer. 2008;113(9):2471-2477

Link1 Link2

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder

Hyun Hwan Sung, Hana Kim, Ryul Kim, Chan Kyo Kim, Ghee Young Kwon, Won Park, Wan Song, Byong Chang Jeong, Se Hoon Park

Investigative and Clinical Urology. 2022;63(2):168

Link1 Link2 Link3

Neoadjuvant Chemotherapy in Muscle Invasive Urothelial Bladder Cancer

Günter Niegisch, Peter Albers

Robotic Urology. 2018;241-248

Link1

Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California

Adrian S. Fairey, Siamak Daneshmand, David Quinn, Tanya Dorff, Ryan Dorin, Gary Lieskovsky, Anne Schuckman, Jie Cai, Gus Miranda, Eila C. Skinner

Urologic Oncology: Seminars and Original Investigations. 2013;31(8):1737-1743

Link1 Link2

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle‐invasive bladder cancer

Nobuaki Matsubara, Hirofumi Mukai, Yoichi Naito, Masahiko Nezu, Kuniaki Itoh

Asia-Pacific Journal of Clinical Oncology. 2012;9(4):310-317

Link1 Link2 Link3 Link4

Muscle-Invasive Urothelial Carcinoma of the Bladder: Neoadjuvant Chemotherapy Enables Organ-Preserving Therapy in Carefully Selected Patients

Axel Heidenreich

European Urology. 2008;54(1):21-23

Link1 Link2

Conservative treatment in patients with muscle-invasive bladder cancer by transurethral resection, neoadjuvant chemotherapy with gemcitabine and cisplatin, and accelerated radiotherapy with concomitant boost plus concurrent cisplatin – assessment of response and toxicity.

Jadwiga NOWAK-SADZIKOWSKA, Teresa KOWALSKA, Jerzy JAKUBOWICZ, Teresa SZPYTMA

Reports of Practical Oncology & Radiotherapy. 2008;13(6):300-308

Link1 Link2

Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer

Ekaterina Laukhtina, Shahrokh F. Shariat

European Urology. 2022;82(2):242-243

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.